| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M001286200 |
| P698 | PubMed publication ID | 10906322 |
| P50 | author | Valeria Poli | Q35703792 |
| Karen Chapman | Q38524444 | ||
| P2093 | author name string | Seckl JR | |
| Darlington GJ | |||
| MacLeod I | |||
| Lyons V | |||
| Williams LJ | |||
| Rajan V | |||
| P2860 | cites work | Cloning and production of antisera to human placental 11 beta-hydroxysteroid dehydrogenase type 2 | Q24534167 |
| Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor | Q24561876 | ||
| Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei | Q27860728 | ||
| Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme | Q28115363 | ||
| Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated | Q28281477 | ||
| A family of C/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro | Q28296697 | ||
| Firefly luciferase gene: structure and expression in mammalian cells | Q29616519 | ||
| Alkylation interference identifies essential DNA contacts for sequence-specific binding of the eukaryotic transcription factor C/EBP | Q33596869 | ||
| Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2. | Q33843488 | ||
| Is CCAAT/enhancer-binding protein a central regulator of energy metabolism? | Q34661217 | ||
| Impaired Energy Homeostasis in C/EBPα Knockout Mice | Q34662358 | ||
| Biological role of the CCAAT/enhancer-binding protein family of transcription factors | Q34663643 | ||
| Cloning and characterisation of the abundant cytoplasmic 7S RNA from mouse cells | Q35521899 | ||
| Glucocorticoid-stimulated CCAAT/enhancer-binding protein alpha expression is required for steroid-induced G1 cell cycle arrest of minimal-deviation rat hepatoma cells | Q36562528 | ||
| 'Liver-type' 11 beta-hydroxysteroid dehydrogenase cDNA encodes reductase but not dehydrogenase activity in intact mammalian COS-7 cells. | Q36714987 | ||
| 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress | Q36833926 | ||
| Identification of an estrogen-responsive element from the 5'-flanking region of the rat prolactin gene | Q36924882 | ||
| CAAT/enhancer binding protein is able to bind to ATF/CRE elements | Q40532197 | ||
| C/EBP alpha: a critical regulator of genes governing integrative metabolic processes | Q41005354 | ||
| 11Beta-hydroxysteroid dehydrogenase 1 in adipocytes: expression is differentiation-dependent and hormonally regulated | Q41036334 | ||
| 11 beta-hydroxysteroid dehydrogenase type 1 expression in 2S FAZA hepatoma cells is hormonally regulated: a model system for the study of hepatic glucocorticoid metabolism | Q41184548 | ||
| The DNA binding domain of the rat liver nuclear protein C/EBP is bipartite | Q41260447 | ||
| Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis | Q41283113 | ||
| Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids | Q41283123 | ||
| Tissue-specific modulation of glucocorticoid action by the 11 beta-hydroxysteroid dehydrogenases | Q41505391 | ||
| Medical and physiological aspects of the 11beta-hydroxysteroid dehydrogenase system | Q41643612 | ||
| Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation | Q41673139 | ||
| Tissue- and temporal-specific regulation of 11beta-hydroxysteroid dehydrogenase type 1 by glucocorticoids in vivo | Q48154643 | ||
| Interactions between oestradiol and glucocorticoid regulatory effects on liver-specific glucocorticoid-inducible genes: possible evidence for a role of hepatic 11beta-hydroxysteroid dehydrogenase type 1. | Q48328332 | ||
| Role of the isoforms of CCAAT/enhancer-binding protein in the initiation of phosphoenolpyruvate carboxykinase (GTP) gene transcription at birth. | Q52192519 | ||
| The Role of C/EBP Isoforms in the Control of Inflammatory and Native Immunity Functions | Q57272895 | ||
| P433 | issue | 39 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hydroxysteroid | Q2157080 |
| P304 | page(s) | 30232-30239 | |
| P577 | publication date | 2000-09-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | C/EBP regulates hepatic transcription of 11beta -hydroxysteroid dehydrogenase type 1. A novel mechanism for cross-talk between the C/EBP and glucocorticoid signaling pathways | |
| P478 | volume | 275 |
| Q36982509 | 11beta-HSD1, inflammation, metabolic disease and age-related cognitive (dys)function |
| Q35599114 | 11beta-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes |
| Q35207794 | 11beta-hydroxysteroid dehydrogenases, cell proliferation and malignancy |
| Q35144168 | 11β-hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress |
| Q37655884 | 11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action |
| Q90164408 | A heretical view: rather than a solely placental protective function, placental 11β hydroxysteroid dehydrogenase 2 also provides substrate for fetal peripheral cortisol synthesis in obese pregnant ewes |
| Q50478905 | A post-weaning fish oil dietary intervention reverses adverse metabolic outcomes and 11β-hydroxysteroid dehydrogenase type 1 expression in postnatal overfed rats. |
| Q34169832 | A switch in hepatic cortisol metabolism across the spectrum of non alcoholic fatty liver disease |
| Q34467039 | Adipogenesis: forces that tip the scales. |
| Q34033578 | C/EBP transcription factors regulate SREBP1c gene expression during adipogenesis |
| Q34221912 | Central glucocorticoid administration promotes weight gain and increased 11β-hydroxysteroid dehydrogenase type 1 expression in white adipose tissue |
| Q52876295 | Changes in gluconeogenesis and intracellular lipid accumulation characterize uremic human hepatocytes ex vivo. |
| Q38084054 | Changing glucocorticoid action: 11β-hydroxysteroid dehydrogenase type 1 in acute and chronic inflammation. |
| Q37990943 | Corticosteroid-induced osteoporosis: an update for dermatologists |
| Q28573234 | DHEA induces 11 -HSD2 by acting on CCAAT/enhancer-binding proteins |
| Q42820080 | Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue |
| Q34222762 | Dietary fatty acid composition alters 11β-hydroxysteroid dehydrogenase type 1 gene expression in rat retroperitoneal white adipose tissue |
| Q42991443 | Differential expression, function and response to inflammatory stimuli of 11beta-hydroxysteroid dehydrogenase type 1 in human fibroblasts: a mechanism for tissue-specific regulation of inflammation |
| Q42830784 | Differential modulation of 3T3-L1 adipogenesis mediated by 11beta-hydroxysteroid dehydrogenase-1 levels |
| Q45005939 | Disruption of hepatic C/EBPalpha results in impaired glucose tolerance and age-dependent hepatosteatosis. |
| Q53882426 | Effects of leptin and dexamethasone on long and short leptin receptor mRNA. |
| Q52641727 | Enhanced hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to diet-induced visceral adiposity. |
| Q35578270 | Enzymology and Molecular Biology of Glucocorticoid Metabolism in Humans |
| Q41959238 | Evidence for transcript-specific epigenetic regulation of glucocorticoid-stimulated skeletal muscle 11β-hydroxysteroid dehydrogenase-1 activity in type 2 diabetes |
| Q42808708 | Fructose promotes the differentiation of 3T3-L1 adipocytes and accelerates lipid metabolism. |
| Q35937728 | G6PT-H6PDH-11βHSD1 triad in the liver and its implication in the pathomechanism of the metabolic syndrome. |
| Q39962795 | Glucocorticoid regulation of the promoter of 11beta-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-beta |
| Q37062092 | Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects |
| Q36848804 | Glucocorticoid-induced osteoporosis: pathophysiology and therapy |
| Q37146798 | Increased glycogen synthase kinase-3β and hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to glucocorticoid-induced mouse visceral adiposity |
| Q28235230 | Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 in obesity |
| Q35227088 | Insulin, CCAAT/enhancer-binding proteins and lactate regulate the human 11β-hydroxysteroid dehydrogenase type 2 gene expression in colon cancer cell lines |
| Q34071494 | Neonatal overfeeding induced by small litter rearing causes altered glucocorticoid metabolism in rats |
| Q35006048 | Pro-inflammatory cytokine induction of 11β-hydroxysteroid dehydrogenase type 1 in A549 cells requires phosphorylation of C/EBPβ at Thr235 |
| Q55058115 | Programming for increased expression of hippocampal GAD67 mediated the hypersensitivity of the hypothalamic-pituitary-adrenal axis in male offspring rats with prenatal ethanol exposure. |
| Q41259479 | Reciprocal regulation of 11β-hydroxysteroid dehydrogenase 1 and glucocorticoid receptor expression by dexamethasone inhibits human coronary artery smooth muscle cell proliferation in vitro |
| Q35107284 | Regulation of 11β-hydroxysteroid dehydrogenase type 1 and 7α-hydroxylase CYP7B1 during social stress |
| Q34291446 | Regulation of adipocyte 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) by CCAAT/enhancer-binding protein (C/EBP) β isoforms, LIP and LAP. |
| Q34628676 | Sequential regulation of diacylglycerol acyltransferase 2 expression by CAAT/enhancer-binding protein beta (C/EBPbeta) and C/EBPalpha during adipogenesis |
| Q36543249 | Sex-Dependent effects of developmental arsenic exposure on methylation capacity and methylation regulation of the glucocorticoid receptor system in the embryonic mouse brain |
| Q36720586 | Sexually dimorphic effects of maternal nutrient reduction on expression of genes regulating cortisol metabolism in fetal baboon adipose and liver tissues. |
| Q51925043 | Stimulation of 11β-HSD1 expression by IL-1β via a C/EBP binding site in human fetal lung fibroblasts. |
| Q37190220 | Th2 cytokine-induced upregulation of 11beta-hydroxysteroid dehydrogenase-1 facilitates glucocorticoid suppression of proasthmatic airway smooth muscle function |
| Q37732574 | The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights |
| Q24657968 | The biological actions of dehydroepiandrosterone involves multiple receptors |
| Q37629023 | Transgenic overexpression of hexose-6-phosphate dehydrogenase in adipose tissue causes local glucocorticoid amplification and lipolysis in male mice |
| Q39904526 | Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells |
| Q35902915 | Ubiquitin-specific protease 2 regulates hepatic gluconeogenesis and diurnal glucose metabolism through 11β-hydroxysteroid dehydrogenase 1 |
| Q35123910 | Vitamin A decreases pre-receptor amplification of glucocorticoids in obesity: study on the effect of vitamin A on 11beta-hydroxysteroid dehydrogenase type 1 activity in liver and visceral fat of WNIN/Ob obese rats |
Search more.